Marianne S.
- Country
- Denmark
- Department
- CF Center, Copenhagen and Pediatric Pulmonary Unit Pediatric Department 5003
Research Overview
- Long-term Safety and Efficacy Evaluation of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Aged 12 Months and Older
- Phase 3 Open-Label Study on Pharmacokinetics, Safety, and Tolerability of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Aged 12 to <24 Months
- Phase 3 Evaluation of Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Combination in Pediatric Cystic Fibrosis Patients
Data & Insights
Has run more than one trial at 5 of 12 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in treating cystic fibrosis, focusing on innovative therapeutic approaches for patients across different age groups, from young children to adults.
- Pediatric Respiratory Care
- Genetic Respiratory Disorders
- Long-term Disease Management
The investigator's work encompasses comprehensive treatment strategies for respiratory conditions, particularly in managing chronic genetic disorders.
Pediatric Medicine
With particular expertise in treating young patients, this investigator focuses on therapeutic interventions for children as young as 12 months of age with genetic respiratory conditions.
- Early Intervention Strategies
- Developmental Medicine
- Pediatric Drug Safety
The investigator's practice emphasizes age-appropriate therapeutic approaches for young patients with chronic conditions.
Clinical Therapeutics
The investigator specializes in evaluating long-term safety profiles and therapeutic efficacy of complex medical treatments for genetic disorders.
- Treatment Safety Assessment
- Therapeutic Monitoring
- Clinical Efficacy Evaluation
Their work focuses on establishing the long-term viability and effectiveness of therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.